DGFT Fixes Export Quota For Covid Test Kits, Asks Exporters To Apply Online From Aug 10-17

Mumbai : The Directorate General Of Foreign Trade (DGFT) has fixed a quota for export of diagnostic kits and their components/laboratory reagents for three months starting July, 2021 and invited online applications from exporters for the same from August 10-17.

As per the DGFT notification on August 9, 2021, exporters can make outbound shipments of 2504 lakh RT-PCR kits from July-September 2021.

Similarly, exporters have been allowed to export 886 lakh RNA extraction kits or its component elements (silicone columns, poly adenylic acid or carrier RNA, proteinase K, magnetic stands, beads) for the three months.

The directorate has allowed export of 1,700 lakh VTM kits or its component elements (15 ml falcon tube or cryovials, sterile synthetic fibre swabs (nylon, polyster, rayon or Dacron) for the same period.

Exporters are requested to apply online for export of diagnostic kits (VTM/RNA extraction kits/RT-PCR kits) or their components/laboratory reagents for the above quantities from August 10-17, 2021, stated the DGFT notification.

Exporters have been asked to apply for an export license by filing applications online through DGFT’s ECOM system for export authorizations (non-SCOMET restricted items).

It is noteworthy that validity of the export license will be for six months only.

The eligibility criteria which will be applicable for consideration of applications include documentary proof of manufacturing “VTM/RNA extraction kits/RT-PCR kits, copy of purchase order /invoice and copy of IEC.

The documents to be submitted include undertaking duly signed by the authorized signatory in the company letter head to be submitted by the manufacturer certifying that as on date, all domestic commitments/orders have been fulfilled. All the documents must be duly self-attested by the authorized person of the firm.

Earlier, the directorate had fixed a quota for export of diagnostic kits and their components/laboratory reagents for the period from December, 2020 to February 2021 through trade notice dated January 19, 2021. The exporters were asked to apply online for export of these items from March 4-9, 2021.

In a bid to deal with Covid-19 pandemic, DGFT in a notification on June 10, 2020 has put restriction on export of 15ml falcon tube or cryovials, swabs sterile synthetic fibre swabs (nylon, polyester, rayon or Dacron), silicon columns, poly adenylic acid or carrier RNA, proteinase K, magnetic stand, beads, probes (specific for Covid-19 testing), primers (specific for Covid-19 testing), taq polymerase enzyme, reverse transcriptase enzyme, deoxy nucleotide triphosphates amid surge in coronavirus cases.

The export of all these products was allowed before the notification.

  • Related Posts

    Brain organoid maturation is driven by a lifelike developmental clock: Study

    A National Institutes of Health (NIH)-funded scientific team has shown that under the right circumstances, 3D cell culture models of human brain tissue, known as organoids, can express features of…

    Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

    New Delhi: The Delhi Police Crime Branch has busted a major interstate syndicate allegedly involved in the illegal procurement, diversion, storage, repackaging and sale of counterfeit and illegally obtained high-value…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Brain organoid maturation is driven by a lifelike developmental clock: Study

    Brain organoid maturation is driven by a lifelike developmental clock: Study

    Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

    Delhi Police Bust ₹9-Crore Interstate Cancer Drug Diversion Network: 17 Arrested; 588 Anti-Cancer Vials, ₹50 Lakh Cash Seized

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    ‘Smart’ Cancer Drug RK-251 Developed by Indian Scientists Could Offer Targeted Alternative to Chemotherapy

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000